
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
Keywords: بی اختیاری; Add-on therapy; Incontinence; Mirabegron; Overactive bladder; Solifenacin;